Gene Bio Medical has achieved positive net present value with a comprehensive IP portfolio. Our competitive advantages include:
1. Tested technology feasibility;
2. Track record of financial performance;
3. Proven ability to scale manufacturability;
4. Existing collaborations with ecosystem partners;
5. Demonstrated attractive unit economics;
6. Validate market demand with clients’ orders.
The company’s approach to scaling its business involves utilizing market trends and commercial sales research, connecting with innovators for commercialization, client acquisition and retention, and continuous localization.
We have a healthcare value chain that includes raw materials supply, research & development, manufacturing, commercialization, and global sales networks.